Supplementation of High Velocity Nasal Insufflation with a Nonrebreather Mask for Severe Hypoxemic Respiratory Failure in Adult Patients with COVID-19
- PMID: 35656503
- PMCID: PMC9155977
- DOI: 10.1155/2022/5004108
Supplementation of High Velocity Nasal Insufflation with a Nonrebreather Mask for Severe Hypoxemic Respiratory Failure in Adult Patients with COVID-19
Abstract
The unique clinical features of COVID-19-related acute hypoxemic respiratory failure, as well as the widespread impact leading to resource strain, have led to reconsiderations of classic approaches to respiratory support. HFNO includes high flow nasal cannula (HFNC) and high velocity nasal insufflation (HVNI). There are currently no widely accepted criteria for HFNO failure. We report a series of three patients who experienced COVID-19-related acute severe hypoxemic respiratory failure. Each patient was initially managed with HVNI and had a ROX index < 3.85, suggesting HFNO failure was likely. They were subsequently managed with a nonrebreather mask (NRM) overlying and in combination with HVNI at maximal settings and were able to be managed without the need for invasive mechanical ventilation.
Copyright © 2022 Jessica S. Whittle et al.
Conflict of interest statement
JW became employed by Vapotherm, Inc. as VP of Clinical Research, after this manuscript was submitted. JG has served as a consultant to Vapotherm, Inc. within the last 3 years for the development of educational materials. LV is a Research Scientist with Vapotherm, Inc. JS has no disclosure.
Similar articles
-
Addition of Mask to High-flow Nasal Oxygen: A Strategy to Improve Oxygenation in Hypoxemic Respiratory Failure Secondary to COVID-19.J Assoc Physicians India. 2024 Jun;72(6):49-53. doi: 10.59556/japi.72.0411. J Assoc Physicians India. 2024. PMID: 38881135
-
The ventilatory effect of high velocity nasal insufflation compared to non-invasive positive-pressure ventilation in the treatment of hypercapneic respiratory failure: A subgroup analysis.Heart Lung. 2020 Sep-Oct;49(5):610-615. doi: 10.1016/j.hrtlng.2020.03.008. Epub 2020 Apr 6. Heart Lung. 2020. PMID: 32273085 Clinical Trial.
-
Reducing aerosol dispersion by high flow therapy in COVID-19: High resolution computational fluid dynamics simulations of particle behavior during high velocity nasal insufflation with a simple surgical mask.J Am Coll Emerg Physicians Open. 2020 Jun 11;1(4):578-591. doi: 10.1002/emp2.12158. eCollection 2020 Aug. J Am Coll Emerg Physicians Open. 2020. PMID: 32838373 Free PMC article.
-
The ROX index as a predictor of high-flow nasal cannula outcome in pneumonia patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.BMC Pulm Med. 2022 Apr 1;22(1):121. doi: 10.1186/s12890-022-01914-2. BMC Pulm Med. 2022. PMID: 35365110 Free PMC article.
-
The value of ROX index in predicting the outcome of high flow nasal cannula: a systematic review and meta-analysis.Respir Res. 2022 Feb 17;23(1):33. doi: 10.1186/s12931-022-01951-9. Respir Res. 2022. PMID: 35177091 Free PMC article.
References
-
- Leonard S., Atwood C. W., Jr., Walsh B. K., et al. Preliminary findings on control of dispersion of aerosols and droplets during high-velocity nasal insufflation therapy using a simple surgical mask: implications for the high-flow nasal cannula. Chest . 2020;158(3):1046–1049. doi: 10.1016/j.chest.2020.03.043. - DOI - PMC - PubMed
-
- Leonard S., Strasser W., Whittle J. S., et al. Reducing aerosol dispersion by high flow therapy in COVID-19: high resolution computational fluid dynamics simulations of particle behavior during high velocity nasal insufflation with a simple surgical mask. Journal of the American College of Emergency Physicians Open . 2020;1(4):578–591. doi: 10.1002/emp2.12158. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources